Completed

MDBF-CIPA New Monitor to Measure Dermal Blood Flow in Critically Ill Patients: a Preliminary Study

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Dermal blood flow measurements

Other
Who is being recruted

Pathologic Processes+5

+ Respiration Disorders

+ Respiratory Insufficiency

Over 18 Years
+2 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Basic Science Study

Interventional
Study Start: June 2003
See protocol details

Summary

Principal SponsorRabin Medical Center
Last updated: February 18, 2013
Sourced from a government-validated database.Claim as a partner

Study start date: June 1, 2003

Actual date on which the first participant was enrolled.

DBF, finger plethysmography and invasive mean arterial pressure (MAP) were recorded over an 8-hour period. DBF was measured using the I.S. MedTech DBF monitor, based on the hot-wire principle of thermal balance of a heater cooled by a moving medium, via a skin probe placed on the anterior chest wall. Sensitivity was evaluated by visual inspection during active states, either induced, e.g. fluid administration, or spontaneous, e.g. altered hemodynamics. Specificity was evaluated during stable states (minimal fluctuations of MAP and no active interventions applied or required). Data are expressed in terms of standard deviation (SD) and of the difference (SDD) between the MAP and each of the tested methods.

NCT01794468
Principal SponsorRabin Medical Center
Last updated: February 18, 2013
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

11 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Basic Science Study

Basic science studies help researchers understand how the body works or how a disease develops. They don't test treatments, but they build the foundation for future therapies.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Pathologic ProcessesRespiration DisordersRespiratory InsufficiencyRespiratory Tract DiseasesPathological Conditions, Signs and SymptomsDisease AttributesCritical IllnessPositive-Pressure Respiration, Intrinsic

Criteria

1 inclusion criteria required to participate
All patients were ventilated and sedated during an 8-hour period of measurement
1 exclusion criteria prevent from participating
Age < 18 years old

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Dermal blood flow was measured with the Dermal Blood Flow (DBF) monitor

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

ICU dep't , Rabin MC

Petah Tikva, IsraelOpen ICU dep't , Rabin MC in Google Maps
CompletedOne Study Center